Filing Details
- Accession Number:
- 0001181431-10-032234
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-09 13:00:00
- Reporting Period:
- 2010-06-07
- Filing Date:
- 2010-06-09
- Accepted Time:
- 2010-06-09 15:08:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385830 | Neurogesx Inc | NGSX | Pharmaceutical Preparations (2834) | 943307935 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1293633 | S Bradford Goodwin | C/O Neurogesx, Inc. 2215 Bridgepointe Parkway, Suite 200 San Mateo CA 94404 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-06-07 | 6,000 | $7.33 | 6,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2010-06-08 | 4,000 | $7.18 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $7.290 to $7.350 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $7.159 to $7.210 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
